Therapeutic monitoring
Lithium monitoring: read the patient before the number
A lithium concentration without a dose time is an incomplete result. A familiar dose does not make a new illness or an over-the-counter medicine harmless. Connect the sample, symptoms and changes in clearance before deciding what a case is asking.
Sources checked October 6, 2026. Independent educational content, not NABP exam questions or individual treatment advice.
Write down both clocks
Record when the last dose was taken and when blood was drawn. The cited lithium carbonate tablet label calls for sampling immediately before the next dose when concentrations are relatively stable, around 8 to 12 hours after the previous dose. A sample drawn shortly after ingestion is not interchangeable with that sample.
Use the specific formulation and monitoring plan. If the timing is missing, recover it rather than calling an unexplained number a trough. Do not infer a safe dose adjustment from a single mistimed result.
Look for a new clearance problem
Lithium is primarily eliminated through the kidneys. Diarrhea, prolonged sweating, dehydration or sodium depletion can change the risk even when the prescription has not changed. Ask about illness and intake as well as the medication list.
New vomiting, worsening tremor, poor coordination or confusion need prompt assessment. Do not dismiss symptoms because an older concentration was satisfactory. Clinical assessment and laboratory findings belong together.
Count nonprescription medicines
The label warns that starting or stopping NSAIDs can change lithium concentrations, with toxicity reported. A patient may describe an NSAID as an occasional pain tablet rather than a medicine, so a generic question about new prescriptions can miss it.
Review diuretics and other interactions in the full current label, including changes and discontinuations. An interaction screen is a starting point, not a substitute for the actual product, exposure and renal context.
Choose the missing fact before the dose
A good answer explains why the available information is insufficient. Separate the immediate safety assessment from the later plan for a correctly timed repeat sample. Do not recommend waiting for a routine appointment when neurological symptoms raise concern.
The exercise is about recognizing a monitoring problem. It does not supply a universal therapeutic target or authorize withholding, restarting or changing an individual patient's dose without clinical assessment.
A worked case
A patient on stable lithium reports two days of diarrhea, new ibuprofen use and unsteady walking. A concentration was drawn two hours after the morning dose. What comes before adjusting the dose from that number?
- Identify symptoms and dehydration as immediate safety concerns, not just a laboratory timing issue.
- Recover the formulation, dose and blood-draw times; the two-hour result is not the cited predose sample.
- Escalate for prompt clinical assessment, including renal function and interactions, rather than declaring the patient safe from the number alone.
Answer: Assess possible toxicity and the changed clearance context; do not treat the mistimed result as a routine trough.
Try it before reading the answer
Write the key fact, decision and safety check first. These are original practice exercises, not recalled exam items.
1. Is a two-hour postdose concentration equivalent to the cited predose sample?
No. Preserve the sample timing and interpret it in the specific clinical and formulation context.
2. Does an unchanged dose exclude a new toxicity risk?
No. Illness, fluid or sodium changes, kidney function and interacting medicines can change risk.
3. Should neurological symptoms be ignored if a previous level was normal?
No. Current symptoms need prompt assessment; an older result cannot establish present safety.
Continue learning
Put the topic into a study planSources and scope
Source dates and limits matter. Follow the current official source for clinical or regulatory decisions. Examples are simplified teaching cases, not prescribing, diagnostic or compounding instructions. Check the full current guidance and individual clinical context.